The MAGEC spinal bracing and distraction system (Ellipse Technologies Inc.) is used in children aged 2 years or over to brace the spine during growth and minimise the progression of scoliosis. This is a Guidance Update of MTG18, following the Guidance Review decision of December 2019. Suspended due to ongoing MHRA investigation into the device
This is suspended due to ongoing MHRA investigation into the device
- Status:
- Discontinued
- Decision:
- Prioritised
- Process:
- MTG
- ID number:
- 169
Email enquiries
If you have any queries please email Medtech@nice.org.uk
Stakeholders
- External assessment group
- Newcastle upon Tyne Hospitals
- Manufacturers
- NuVasive, Inc.
- Professional groups
- Association of British Healthcare Industries (ABHI)
- Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
- Boston Scientific
- Department of Health and Social Care
- Devices for Dignity
- Greater Manchester Health & Social Care Partnership
- Healthcare Improvement Scotland
- HealthTech Alliance
- Johnson & Johnson Medical Ltd
- Medical Technology Group
- Medicines and Healthcare Products Regulatory Agency
- NHS England
- The British In Vitro Diagnostics Association (BIVDA)
Related links
- MTG18 Guidance Review Decision
- MTG18 The MAGEC system for spinal lengthening in children with scoliosis
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 22 December 2021 | Discontinued. This is suspended due to ongoing MHRA investigation into the device |
| 03 August 2020 | Resolution |
| 24 April 2020 | Committee meeting: 1 |
| 06 February 2020 | Scope published |
For further information on our processes and methods, please see our CHTE processes and methods manual